Skip to main content
  • Register
  • Login
Sort By
Narwhal Menu
  • Search
  • Menu
  • About Sandoz
    • About Sandoz
    • Contact Us
  • Therapy Areas
    • Therapy Areas
    • Anti-Infectives
      • Respiratory Tract Infections
      • Skin Infections
      • Urinary Tract Infections
    • CNS
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Bipolar Disorder
      • Insomnia
      • Migraine
      • Schizophrenia
    • Cardiovascular
      • Dyslipidemia
      • Hypertension
      • Thrombosis
    • Endocrinology
      • Diabetes
      • Growth Hormone Deficiency (GHD)
    • Gastrointestinal Tract
      • Gastro-oesophageal Reflux Disease (GORD)
      • Heartburn
    • Immunology
      • Rheumatology
      • Dermatology
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Ovarian Cancer
      • Prostate Cancer
      • Supportive Care
    • Pain
      • Acute Pain
      • Chronic Pain
    • Respiratory
      • Wet Cough and Sinus Congestion
    • Transplant
      • Heart Transplant
      • Kidney Transplant
      • Liver Transplant
    • Travel Sickness and Vertigo
      • Ménière's Disease
      • Travel Sickness
    • Vitamins & Minerals
      • Calcium and Vitamin D Supplementation
  • Our Products
    • Our Products
  • News & Stories
    • News & Stories
    • Choose Sandoz for Biosimilars
    • Corporate Responsibility
    • Listening to Patient Perspectives
    • Ushering in the next wave of Biosimilars by unlocking their potential
  • Sandoz SA PAIA Manual
    • Sandoz SA PAIA Manual
  • Search
Liver Transplant - Desktop

Transplant

  1. Home
  2. Therapy Areas
  3. Transplant
  4. Liver Transplant

Liver Transplant

Liver transplantation is a life-saving surgery for the treatment of suitable patients with end-stage liver disease and some types of liver cancer.1

Both living-donor and deceased-donor liver transplants are possible.2

The outcome of liver transplantation has markedly improved over the last three decades.3 With current immunosuppression regimens, the rate of acute rejection after liver transplantation is low.3 Chronic rejection is also very uncommon.3

Liver Transplant.jpg

Immunosuppressive medication is one of the most important factors in the treatment outcome for liver transplant patients.1 

Nonadherence to immunosuppressive therapy after transplantation affects the success of the transplant and the survival of patients, yet 15–40% of patients do not take their immunosuppressive medications regularly.1 This is one of the leading causes of liver transplant failure.1

Whilst various complex factors play a role in non-compliance with post-organ-transplant immunotherapy, cost is one of the possible issues.4 Immunotherapy medications are a major component of total expenditure after organ transplantation,4 which is why high-quality generic post-transplant immunotherapy medications are needed.

Sandoz and Novartis have over 40 years of experience in transplant care and Sandoz is the #1 provider of generic transplant medications in Europe.5 We are proud of our ability to help patients maintain the optimum immunosuppression medication dosing which is so critical to transplant care.5

References
1.

Promraj R, Dumronggittigule W, Sirivatanauksorn Y, et al. Immunosuppressive Medication Adherence in Liver Transplant Recipients. Transplantation Proceedings. 2016;48(4):1198-1201. doi:10.1016/j.transproceed.2015.12.097

2.

Botha JF, Ströbele B, Loveland JA, et al. Living Donor Liver Transplantation in South Africa: The Donor Experience. South African Journal of Surgery. 2019;57(3):11-16. doi:10.17159/2078-5151/2019/v57n3a2998

3.

Durand F. How to Improve Long-term Outcome After Liver Transplantation? Liver Int. 2018;38 Suppl 1:134-138. doi:10.1111/liv.13651

4.

Laederach-Hofmann K, Bunzel B. Noncompliance in Organ Transplant Recipients: A Literature Review. Gen Hosp Psychiatry. 2000;22(6):412-424. doi:10.1016/s0163-8343(00)00098-0

5.

Sandoz. News – Media Releases – Sandoz Launches Once-daily Generic Tacrolimus for Transplant Patients in Europe [Online]. Cited 4 Sep 2021. Available from:  https://www.sandoz.com/news/media-releases/sandoz-launches-once-daily-generic-tacrolimus-transplant-patients-europe

My Sandoz

Navigate My Sandoz
  • Home
  • About Sandoz
  • Therapy Areas
  • Our Products
  • News & Stories
  • Sandoz SA PAIA Manual

ZA2109032375

©2023 Sandoz South Africa

Footer Bottom Links
  • Cookie Settings
  • Terms of Use
  • Website Privacy Policy
  • Business Partner Privacy Policy
  • Site Map
Sandoz Site Directory.

This site is intended for medical professionals within South Africa.